Navigation Links
iSirona Announces New President and Chief Sales Officer
Date:12/11/2008

Former President to Lead Company as CEO

Panama City, FL (PRWEB) December 11, 2008 -- iSirona®, an innovative provider of data automation solutions for healthcare providers, today announced that Peter Witonsky has been named president and chief sales officer. The management team expansion is in response to iSirona's rapid growth over the past 12 months. Company founder and former President Dave Dyell will continue on with the company as chief executive officer.

Witonsky has 15 years of experience in business development and sales leadership in the healthcare payer, provider and vendor markets. Prior to joining iSirona, Witonsky served as director of business development for North and South America while at Metrologic, where he grew the healthcare business by 200%. While director of business development at Falcon Capital Partners, he participated in healthcare mergers, acquisitions and recapitalization projects that totaled over $200 million. In addition, he was responsible for sales to major hospital integrated delivery networks while with McKesson Corporation.

"Peter Witonsky's proven abilities in the healthcare industry will be invaluable to our customers as they seek solutions to their data automation needs," says CEO Dave Dyell. "His understanding of the industry's complexities coupled with his strategic vision is a true asset for iSirona."

Adds Witonsky, "More than ever, healthcare needs innovative solutions that improve nursing efficiency and clinical workflow. With its impressive technology, burgeoning market potential and seasoned management team, I see great potential in iSirona and look forward to building on the company's current momentum."

About iSirona
Panama City, Florida-based iSirona (www.isirona.com) develops clinical automation solutions for healthcare. The iSirona Enterprise™ product suite delivers medical device data from bedside and mobile devices to clinical information systems, simplifying the process of patient data collection. iSirona accelerates return-on-investment by streamlining workflow and maximizing IT investments. Uniquely positioned to deliver the most robust solution, iSirona guarantees delivery of accurate, timely and complete patient data.

###

Read the full story at http://www.prweb.com/releases/2008/12/prweb1734984.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... ... Guajardo Carothers is not your typical author. She went from working as a movie extra ... about God, when she isn’t swimming as a performing mermaid. , Her book isn’t typical ... she offers a comedic look at the dysfunctions of God’s family, before Lucifer was sent ...
(Date:2/27/2017)... ... ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines from the International Lyme and Associated ... Disease Control ( CDC ) and Infectious Diseases Society of America (IDSA) dismiss any ... into a single volume a compelling argument that the disease does exist in his ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... Francisco and environs, is proud to announce an upgrade to the company's Yelp ... upgraded Yelp page on topics as diverse as Platelet Rich Plasma (PRP) therapy, ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... lab became the world’s first to be ISO/IEC 17025:2005 INAB accredited for Der ... , ISO/IEC 17025:2005 is the globally recognised standard that sets out requirements for ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... in staffing, scheduling, and reporting for healthcare organizations. This comprehensive and customizable ... entire staffing process. StaffBridge technology improves staffing efficiency, maximizes resource allocation, collects ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced the ... and Chief Executive Officer (CEO) and member of the Board ... Richard Love , interim President and CEO who will continue ... has over 20 years of experience in hematology, oncology and ... . "On behalf of CTI BioPharma,s Board, ...
(Date:2/24/2017)... Following receiving CE Marking in ... s AMAR is a major milestone for the country where the ... ound care market in Israel ... for inclusion in the National Health Basket , Israel ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment ...
(Date:2/24/2017)... , Feb 24, 2017 Research and Markets ... and Strategies - 2016" report to their offering. ... The latest research Dry eye Drugs Price ... the global Dry eye market. The research answers the following questions: ... Dry eye and their clinical attributes? How are they positioned in the ...
Breaking Medicine Technology: